Locoregional Recurrence Clinical Trials
1 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 2
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
Locoregional Recurrence
Oana Danciu200 enrolled20 locationsNCT05467891
Recruiting
Postoperative Re-irradiaTion With and Without HYPERthermia: Toxicity, Quality of Life and Survival in Patients With Locoregional Recurrent Breast Cancer
Breast CancerLocoregional RecurrenceRe-irradiation+1 more
Amsterdam UMC, location VUmc500 enrolled1 locationNCT06452485
Recruiting
Phase 3
Adjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA)
Breast CancerAbemaciclibLocoregional Recurrence+1 more
Japanese Foundation for Cancer Research290 enrolled1 locationNCT07190443